RNF168 and ovarian carcinoma: The results showed that the overexpression of LOC730101 significantly increased the expression of p62, and decreased the expression of RNF168 and H2AK119ub compared with the control group after the treatment of ovarian cancer cells with cisplatin and niraparib respectively (Fig. 7D).